science

Non-racemic MDMA

Non-racemic MDMA is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Non-racemic MDMA rather than just read about it. In short: Non-racemic MDMA, also known by the developmental code names ALA-002 and AM-1002, are non-racemic mixtures of the MDMA (midomafetamine; "ecstasy") enantiomers (R)-MDMA and (S)-MDMA which are under development for the treatment of social phobia (social anxiety disorder; SAD), autistic spectrum disorder (ASD), and generalized anxiety disorder (GAD). ALA-002, which is under development by PharmAla Biotech for social ph…

Key takeaways

Non-racemic MDMA belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Non-racemic MDMA to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Non-racemic MDMA from memory before moving on to harder problems.

Reference excerpt

Non-racemic MDMA, also known by the developmental code names ALA-002 and AM-1002, are non-racemic mixtures of the MDMA (midomafetamine; "ecstasy") enantiomers (R)-MDMA and (S)-MDMA which are under development for the treatment of social phobia (social anxiety disorder; SAD), autistic spectrum disorder (ASD), and generalized anxiety disorder (GAD). ALA-002, which is under development by PharmAla Biotech for social phobia and autistic spectrum disorders, is a mixture of 70–80% (R)-MDMA and 20–30% (S)-MDMA. Conversely, AM-1002, which is under development by Arcadia Medicine for GAD, is a mixture of 90% (R)-MDMA and 10% (S)-MDMA. Based on animal studies, (R)-MDMA-preferring non-racemic MDMA mixtures show less hyperlocomotion, hyperthermia, hypertension, and neurotoxicity than racemic MDMA. ALA-002 is in phase 2 clinical trials for SAD and ASD as of 2026, whereas AM-1002 is in phase 1/2 trials for GAD as of 2026. Jupiter Neurosciences acquired the exclusive rights to develop ALA-002 in the United States from PharmAla Biotech in May 2026.

See also List of investigational hallucinogens and entactogens List of investigational social anxiety disorder drugs List of investigational autism and pervasive developmental disorder drugs List of investigational generalized anxiety disorder drugs (R)-MDMA (EMP-01, DT402/MM402) APA-01 (APA-001; PharmAla-1)

References

Illustrations

Worked examples

Example 1 — a first encounter with Non-racemic MDMA

Start with the simplest possible case. Write down what Non-racemic MDMA claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Non-racemic MDMA before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Non-racemic MDMA ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Non-racemic MDMA

In research: Non-racemic MDMA appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Non-racemic MDMA in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Non-racemic MDMA is common in secondary-school and first-year university syllabi. It links to neighbouring topics Combination drugs, Entactogens, Experimental anxiolytics, so understanding it makes those chapters shorter.
In everyday life: Look for Non-racemic MDMA outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Non-racemic MDMA” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Non-racemic MDMA in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Non-racemic MDMA means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Non-racemic MDMA out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Non-racemic MDMA in simple terms?

Why does Non-racemic MDMA matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Non-racemic MDMA?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Non-racemic MDMA.